Discover investment opportunities in Top 5 Stocks Under $2 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top 5 Stocks Under $2 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top 5 Stocks Under $2 using our Smart AI Filter.
6 stocks found for "Top 5 Stocks Under $2"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
1.40 | ±59.3% | -45.5 | 0.00% | |||
0.71 | ±56.0% | -26.5 | 0.00% | |||
0.83 | ±61.9% | -3.1 | 0.00% | |||
0.25 | ±49.2% | 8.0 | 0.00% | |||
2.07 | ±100.0% | -4.2 | 0.00% | |||
1.56 | ±82.7% | -121.0 | 0.00% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Senseonics (SENS) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Read moreOn Friday, a day after Israel launched 'Operation Rising Lion' targeting over 100 Iranian nuclear and military sites, Iran retaliated with missile attacks on Israel. The strikes marked the start of what Iranian state media called 'The Hard Retaliation.
Read moreQ: What are the potential growth opportunities for PEDEVCO Corp (PED)?
A: PEDEVCO Corp (PED) operates in the oil and gas sector, primarily focusing on energy resource development. Potential growth opportunities arise from favorable oil market trends, strategic acquisitions, and technological advancements in extraction methods. Investors often consider the impact of oil prices on PED's revenue projections.
Q: How does Bitfarms Ltd (BITF) perform during cryptocurrency market fluctuations?
A: Bitfarms Ltd (BITF), a cryptocurrency mining company, is highly sensitive to changes in cryptocurrency prices. During bullish phases, revenue can increase sharply with higher demand and prices, but downturns in the crypto market can result in significant revenue declines and increased operational risks.
Q: What are the risk factors associated with investing in Denison Mines Corp (DNN)?
A: Risks for Denison Mines Corp (DNN), a uranium mining company, include fluctuating uranium prices, regulatory challenges, and geopolitical tensions affecting mining operations. Investors should consider the broader energy market and renewable energy trends when evaluating these risks.
Q: What is the income potential of Senseonics Holdings (SENS) regarding medical technology?
A: Senseonics Holdings (SENS) specializes in continuous glucose monitoring systems. Its income potential is tied to the growing demand for diabetes management solutions and innovations in medical technology. FDA approvals and product adoption rates play critical roles in influencing revenue growth.
Q: Does Atossa Therapeutics Inc (ATOS) offer stability in biotech investments?
A: Atossa Therapeutics Inc (ATOS) is known for its breast cancer therapies. Due to the high-risk nature of biotech, ATOS's stock stability is dependent on clinical trial successes and regulatory approvals. The volatile nature of biotech R&D often impacts stock performance significantly.
Q: What are the implications of investing in Zomedica Corp (ZOM) in the veterinary health sector?
A: Zomedica Corp (ZOM) delivers veterinary diagnostics and therapeutic solutions. This sector benefits from rising pet ownership and spending on animal health. However, competition from established players and regulatory challenges can influence market positioning and growth potential.